Skip to Content
Merck
  • Hypoxic Preconditioning Maintains GLT-1 Against Transient Global Cerebral Ischemia Through Upregulating Cx43 and Inhibiting c-Src.

Hypoxic Preconditioning Maintains GLT-1 Against Transient Global Cerebral Ischemia Through Upregulating Cx43 and Inhibiting c-Src.

Frontiers in molecular neuroscience (2018-10-17)
Kongping Li, Huarong Zhou, Lixuan Zhan, Zhe Shi, Weiwen Sun, Dandan Liu, Liu Liu, Donghai Liang, Yafu Tan, Wensheng Xu, En Xu
ABSTRACT

Transient global cerebral ischemia (tGCI) causes excessive release of glutamate from neurons. Astrocytic glutamate transporter-1 (GLT-1) and glutamine synthetase (GS) together play a predominant role in maintaining glutamate at normal extracellular concentrations. Though our previous studies reported the alleviation of tGCI-induced neuronal death by hypoxic preconditioning (HPC) in hippocampal Cornu Ammonis 1 (CA1) of adult rats, the underlying mechanism has not yet been fully elaborated. In this study, we aimed to investigate the roles of GLT-1 and GS in the neuroprotection mediated by HPC against tGCI and to ascertain whether these roles can be regulated by connexin 43 (Cx43) and cellular-Src (c-Src) activity. We found that HPC decreased the level of extracellular glutamate in CA1 after tGCI via maintenance of GLT-1 expression and GS activity. Inhibition of GLT-1 expression with dihydrokainate (DHK) or inhibition of GS activity with methionine sulfoximine (MSO) abolished the neuroprotection induced by HPC. Also, HPC markedly upregulated Cx43 and inhibited p-c-Src expression in CA1 after tGCI, whereas inhibition of Cx43 with Gap26 dramatically reversed this effect. Furthermore, inhibition of p-c-Src with 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo (3, 4-d) pyrimidine (PP2) decreased c-Src activity, increased protein levels of GLT-1 and Cx43, enhanced GS activity, and thus reduced extracellular glutamate level in CA1 after tGCI. Collectively, our data demonstrated that reduced extracellular glutamate induced by HPC against tGCI through preventing the reduction of GLT-1 expression and maintaining GS activity in hippocampal CA1, which was mediated by upregulating Cx43 expression and inhibiting c-Src activity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Glutamate Transporter Antibody, Glial, serum, Chemicon®
Sigma-Aldrich
Anti-Glial Fibrillary Acidic Protein (GFAP) Antibody, serum, Chemicon®
Sigma-Aldrich
Goat Anti-Rabbit IgG Antibody, Cy3 conjugate, Chemicon®, from goat
Sigma-Aldrich
Anti-Glial Fibrillary Acidic Protein Antibody, clone GA5, ascites fluid, clone GA5, Chemicon®
Sigma-Aldrich
Anti-NeuN Antibody (rabbit), from rabbit, purified by affinity chromatography
Sigma-Aldrich
Goat Anti-Rabbit IgG Antibody, (H+L) FITC conjugate, 1.0 mg/mL, Chemicon®
Sigma-Aldrich
Goat Anti-Guinea Pig IgG Antibody, FITC conjugate, Chemicon®, from goat
Sigma-Aldrich
Goat Anti-Mouse IgG Antibody, Cy3 conjugate, Chemicon®, from goat
Sigma-Aldrich
Anti-Glutamine Synthetase Antibody, clone GS-6, clone GS-6, Chemicon®, from mouse
Sigma-Aldrich
Anti-Connexin 43 Antibody, clone 4E6.2, clone 4E6.2, Chemicon®, from mouse
Sigma-Aldrich
Anti-NeuN Antibody, clone A60, clone A60, Chemicon®, from mouse